SCHEMBL5545852

SCHEMBL5545852

NOCC(=O)Nc1cccc(-c2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.60
MGLL Q99685 3/20 0.60
HDAC6 Q9UBN7 6/20 0.57
HDAC1 Q13547 5/20 0.57
HDAC3 O15379 3/20 0.56
HDAC4 P56524 3/20 0.56
HDAC7 Q8WUI4 3/20 0.56
HDAC2 Q92769 3/20 0.56
HDAC10 Q969S8 3/20 0.56
HDAC11 Q96DB2 3/20 0.56
HDAC8 Q9BY41 3/20 0.56
HDAC9 Q9UKV0 3/20 0.56
HDAC5 Q9UQL6 3/20 0.56
CFD P00746 1/20 0.56
NPC1 O15118 2/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5017614 0.85 HTT (0.62) CYP2C19HDAC6HDAC1HDAC3HDAC4
SCHEMBL4268296 0.85 MAPT (0.59) CYP2C19KDM4ELMNAMAPTHPGD
SCHEMBL7404383 0.82 MGLL (0.66) CYP2C19MGLLHDAC6HDAC1HDAC3
SCHEMBL14075089 0.82 CYP2C19 (0.57) CYP2C19MGLLHDAC6HDAC1HDAC3
SCHEMBL21765474 0.81 SMN1; SMN2 (0.64) NPC1KDM4EMAPTSMN1; SMN2
SCHEMBL16201549 0.80 MGLL (0.68) CYP2C19MGLLHDAC6HDAC1HDAC3
SCHEMBL13476524 0.80 MGLL (0.68) CYP2C19MGLLHDAC6HDAC1HDAC3
SCHEMBL10632034 0.79 MAPT (0.60) NPC1KDM4ELMNAMAPTHPGD
SCHEMBL4003283 0.79 MITF (0.72) MGLLHDAC6HDAC1HDAC3HDAC4
SCHEMBL8404715 0.79 L3MBTL1 (0.67) CYP2C19MGLLHDAC6HDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1830858-A2 3, 6-BICYCLOLIDES Enanta Pharmaceuticals, Inc. (US) 2007-09-12 EP disclosed
WO-2006063039-A2 3, 6-BICYCLOLIDES ENANTA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed